Draft Guidance for Industry on Vaginal Microbicides: Development for the Prevention of Human Immunodeficiency Virus Infection; Availability

Document ID: FDA-2012-D-1120-0001

Comments

Total: 6
Population Council - Comment
Posted : 02/21/2013     ID :FDA-2012-D-1120-0005     Agency : FDA

Feb 21,2013 11:59 PM ET
Merck & Co, Inc. (Merck Research Laboratories) - Comment
Posted : 02/25/2013     ID :FDA-2012-D-1120-0006     Agency : FDA

Feb 21,2013 11:59 PM ET
Christine K. Mauck (CONRAD) - Comment
Posted : 02/25/2013     ID :FDA-2012-D-1120-0007     Agency : FDA

Feb 21,2013 11:59 PM ET
International Partnership for Microbicides (IPM) - Comment
Posted : 02/25/2013     ID :FDA-2012-D-1120-0008     Agency : FDA

Feb 21,2013 11:59 PM ET
AVAC - Comment
Posted : 02/25/2013     ID :FDA-2012-D-1120-0009     Agency : FDA

Feb 21,2013 11:59 PM ET
GlaxoSmithKline - Comment
Posted : 02/25/2013     ID :FDA-2012-D-1120-0010     Agency : FDA

Feb 21,2013 11:59 PM ET